Robert Blum Insider Trades & Stock Holdings

President & CEO · Cytokinetics, Incorporated · Latest filing Jun 15, 2026

Robert Blum, President & CEO at Cytokinetics, Incorporated has 1 Form 4 trade on file since Jun 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($528.45K), net -$528.45K. Latest filing: disposed of 7.50K shares of $CYTK on Jun 15, 2026 at $70.46.

Trades on file

1

Open-market bought

$0

Open-market sold

$528.45K

Net open-market

-$528.45K

Latest filing

Jun 15, 2026

All insider trades by Robert Blum

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$CYTK	Sell (Open-market sale) 10b5-1	7.50K	$70.46	$528.45K			+10.9%	+15.7%		President & CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Robert Blum traded

• $CYTK

Frequently asked questions

Has Robert Blum been buying or selling stock?

Robert Blum has 0 open-market purchases and 1 open-market sale on file, net -$528.45K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Robert Blum's latest insider trade?

disposed of 7.50K shares of $CYTK on Jun 15, 2026 at $70.46.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.